ONTRUZANT® (trastuzumab-dttb) Logo

Please read the Prescribing Information for ONTRUZANT, including the
information about heart problems, infusion reactions (lung problems),
and harm to an unborn baby, and discuss it with your doctor.


HOW MAY WE ASSIST YOU?

THE MERCK ACCESS PROGRAM

CAN HELP ANSWER QUESTIONS LIKE

  • Does my insurance cover ONTRUZANT?
  • What options may be available for co-pay assistance?
  • Am I eligible for referral to the Merck Patient Assistance Program for eligibility determination (provided through the Merck Patient Assistance Program, Inc.)?

A REPRESENTATIVE MAY BE ABLE TO

  • Identify your insurance benefits
  • Obtain information about your out-of-pocket costs for eligible patients
  • Provide information on co-pay assistance options
  • Refer you to the Merck Patient Assistance Program for eligibility determination (provided through the Merck Patient Assistance Program, Inc.)
  • Answer questions about the enrollment form
To get started, select a category above or call 855-257-3932 to speak with a representative.
  • Merck’s Response to Coronavirus (COVID-19)

    During this unprecedented time, Merck is committed to ensuring our medicines reach our patients and customers. If you have concerns that you may have lost your insurance coverage due to the COVID-19 pandemic or may not be able to afford your medication, we encourage you to call The Merck Access Program.

    For more details about Merck’s response to coronavirus, visit our COVID-19 information page.

  • Sign up With the Electronic Enrollment Form With E-Signature

  •  
  •  


 WELCOME TO

THE MERCK ACCESS PROGRAM

ARE YOU A US HEALTH CARE PROFESSIONAL?

Please choose